Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
IMVT Insider Trading: Immunovant, Inc. Insider Buys and Sells · https://wallstpal.com/stock/imvt/insider-trading/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Insider tradingForm 4

Immunovant, Inc. (IMVT) Insider Trading

22 open-market trades reported since Jun 16, 2026: 0 purchases worth $0 and 22 sales worth $5.03M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Jay S. StoutCTO0$05$1.98MOct 23, 2026
Melanie GloriaCOO0$04$966KOct 9, 2026
Van Tuyl ChristopherGeneral Counsel0$05$970KOct 9, 2026
Eric VenkerCEO0$02$239KOct 5, 2026
Atul PandeDirector0$04$233KAug 28, 2026
Tiago GiraoCFO0$02$648KJul 24, 2026

All trades

IMVT insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Oct 23Oct 21Jay S. StoutCTOCTO▼ SELL2,59528.94$75K−1.3%Form 4 ↗
Oct 9Oct 7Jay S. StoutCTOCTO▼ SELL3,80932.06$122K−1.9%Form 4 ↗
Oct 9Oct 7Melanie GloriaCOOCOO▼ SELL2,24132.06$72K−1.0%Form 4 ↗
Oct 9Oct 7Van Tuyl ChristopherGeneral CounselGeneral Counsel▼ SELL1,32732.06$43K−0.8%Form 4 ↗
Oct 5Oct 2Eric VenkerCEOCEO▼ SELL3,50634.11$120K−1.3%Form 4 ↗
Sep 25Sep 23Van Tuyl ChristopherGeneral CounselGeneral Counsel▼ SELL2,84636.36$103K−1.6%Form 4 ↗
Aug 28Aug 28Atul PandeDirectorDirector▼ SELL10b5-11,50043.27$65K−1.3%Form 4 ↗
Aug 21Aug 20Melanie GloriaCOOCOO▼ SELL3,05644.16$135K−1.4%Form 4 ↗
Jul 24Jul 23Tiago GiraoCFOCFO▼ SELL6,79838.69$263K−2.7%Form 4 ↗
Jul 24Jul 23Jay S. StoutCTOCTO▼ SELL2,85738.69$111K−1.4%Form 4 ↗
Jul 24Jul 24Atul PandeDirectorDirector▼ SELL10b5-11,50039.80$60K−1.3%Form 4 ↗
Jul 10Jul 8Jay S. StoutCTOCTO▼ SELL3,48739.55$138K−1.6%Form 4 ↗
Jul 10Jul 8Melanie GloriaCOOCOO▼ SELL2,03639.55$81K−0.9%Form 4 ↗
Jul 10Jul 8Van Tuyl ChristopherGeneral CounselGeneral Counsel▼ SELL1,20639.55$48K−0.7%Form 4 ↗
Jul 6Jul 2Eric VenkerCEOCEO▼ SELL3,09238.48$119K−1.2%Form 4 ↗
Jun 26Jun 26Jay S. StoutCTOCTO▼ SELL40,00038.31$1.53M−16%Form 4 ↗
Jun 26Jun 26Van Tuyl ChristopherGeneral CounselGeneral Counsel▼ SELL17,82438.31$683K−9.0%Form 4 ↗
Jun 26Jun 26Melanie GloriaCOOCOO▼ SELL17,71438.31$679K−7.3%Form 4 ↗
Jun 26Jun 26Tiago GiraoCFOCFO▼ SELL10,00038.46$385K−3.9%Form 4 ↗
Jun 26Jun 26Atul PandeDirectorDirector▼ SELL10b5-11,50038.01$57K−1.3%Form 4 ↗
Jun 22Jun 18Van Tuyl ChristopherGeneral CounselGeneral Counsel▼ SELL2,63435.39$93K−1.4%Form 4 ↗
Jun 16Jun 15Atul PandeDirectorDirector▼ SELL10b5-11,50034.02$51K−1.3%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings